Literature DB >> 27811148

Response to: 'JAK inhibition in STING-associated interferonopathy' by Crow et al.

Victoria Tüngler1, Nadja König1, Claudia Günther2, Kerstin Engel1, Christoph Fiehn3, Martin Smitka4, Maja von der Hagen4, Reinhard Berner5, Min Ae Lee-Kirsch1.   

Abstract

Keywords:  Autoimmunity; Inflammation; Treatment

Mesh：

Substances：

Year:  2016        PMID： 27811148     DOI： 10.1136/annrheumdis-2016-210565

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

Review 1.  [Familial chilblain lupus : Type 1 interferonopathy with model character].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

Review 2.  Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?

Authors:  Christoph Fiehn
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

3.  DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes.

Authors:  Marco Luciani; Francesca Gatto; Monah Abou Alezz; Anna Maria Sole Giordano; Chiara Beghè; Lucrezia Della Volpe; Alessandro Migliara; Sara Valsoni; Marco Genua; Monika Dzieciatkowska; Giacomo Frati; Julie Tahraoui-Bories; Silvia Clara Giliani; Simona Orcesi; Elisa Fazzi; Renato Ostuni; Angelo D'Alessandro; Raffaella Di Micco; Ivan Merelli; Angelo Lombardo; Martin A M Reijns; Natalia Gromak; Angela Gritti; Anna Kajaste-Rudnitski
Journal:  J Exp Med       Date:  2022-03-09       Impact factor: 14.307

Review 4.  Therapeutic Approaches to Type I Interferonopathies.

Authors:  Marc Bienias; Normi Brück; Constanze Griep; Christine Wolf; Stefanie Kretschmer; Barbara Kind; Victoria Tüngler; Reinhard Berner; Min Ae Lee-Kirsch
Journal:  Curr Rheumatol Rep       Date:  2018-04-20       Impact factor: 4.686

Review 5.  JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.

Authors:  George E Fragoulis; Iain B McInnes; Stefan Siebert
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

6.  Aicardi-Goutières syndrome due to a paternal mosaic IFIH1 mutation.

Authors:  Victoria Tüngler; Marion Doebler-Neumann; Michaela Salandin; Peter Kaufmann; Christine Wolf; Nadja Lucas; Florian Harmuth; Jennifer Reichbauer; Ingeborg Krägeloh-Mann; Rebecca Schüle; Min Ae Lee-Kirsch
Journal:  Neurol Genet       Date:  2019-12-19

7.  Ruxolitinib in Aicardi-Goutières syndrome.

Authors:  Eleonora Mura; Silvia Masnada; Clara Antonello; Cecilia Parazzini; Giana Izzo; Jessica Garau; Daisy Sproviero; Cristina Cereda; Simona Orcesi; Pierangelo Veggiotti; Gianvincenzo Zuccotti; Dario Dilillo; Francesca Penagini; Davide Tonduti
Journal:  Metab Brain Dis       Date:  2021-03-15       Impact factor: 3.584
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.